Kjeld Schmiegelow Selected Research

pegaspargase (Oncaspar)

1/2022	Asparaginase encapsulated in erythrocytes as second-line treatment in hypersensitive patients with acute lymphoblastic leukaemia.
1/2021	Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemia.
1/2019	Trypsin-encoding PRSS1-PRSS2 variations influence the risk of asparaginase-associated pancreatitis in children with acute lymphoblastic leukemia: a Ponte di Legno toxicity working group report.
1/2019	Genetic predisposition to PEG-asparaginase hypersensitivity in children treated according to NOPHO ALL2008.
12/2017	Prolonged first-line PEG-asparaginase treatment in pediatric acute lymphoblastic leukemia in the NOPHO ALL2008 protocol-Pharmacokinetics and antibody formation.
9/2017	Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites.
3/2015	PEG-asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol.
1/2015	Serial Ultrasound Monitoring for Early Recognition of Asparaginase Associated Pancreatitis in Children With Acute Lymphoblastic Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kjeld Schmiegelow Research Topics

Disease

98	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022 - 01/2002
44	Neoplasms (Cancer) 05/2022 - 11/2003
17	Pancreatitis 01/2022 - 10/2012
12	Leukemia 01/2022 - 01/2002
10	Hypersensitivity (Allergy) 01/2022 - 10/2012
10	Infections 01/2021 - 01/2002
7	Thromboembolism 01/2022 - 01/2016
7	Fever (Fevers) 01/2020 - 01/2002
6	Residual Neoplasm 01/2022 - 05/2013
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2012 - 09/2004
5	Thrombosis (Thrombus) 01/2022 - 01/2020
5	Osteonecrosis (Kienbock's Disease) 11/2021 - 01/2016
5	Thrombocytopenia (Thrombopenia) 10/2020 - 11/2008
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 06/2013
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 04/2006
4	Lymphoma (Lymphomas) 05/2022 - 05/2012
4	Seizures (Absence Seizure) 01/2022 - 01/2016
4	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2022 - 01/2017
4	Vomiting 01/2022 - 08/2018
4	Nausea 01/2022 - 08/2018
4	Brain Neoplasms (Brain Tumor) 01/2021 - 01/2003
4	Down Syndrome (Down's Syndrome) 01/2021 - 10/2006
4	Mucositis 10/2020 - 01/2017
4	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2020 - 06/2011
3	Central Nervous System Diseases (CNS Diseases) 01/2022 - 09/2004
3	Stomatitis 11/2021 - 07/2012
3	Pain (Aches) 11/2021 - 07/2012
3	Inflammation (Inflammations) 10/2020 - 01/2015
3	Abdominal Pain (Pain, Abdominal) 10/2020 - 01/2017
3	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2017 - 08/2003
3	Neutropenia 01/2015 - 06/2006
2	Anaphylaxis (Anaphylactic Shock) 01/2022 - 03/2015
2	Posterior Leukoencephalopathy Syndrome 01/2022 - 01/2016
2	Hemorrhage 01/2022 - 10/2020
2	Venous Thromboembolism 10/2020 - 05/2020
2	Bacteremia 01/2020 - 01/2017
2	Philadelphia Chromosome 01/2020 - 02/2016
2	Hyperlipidemias (Hyperlipidemia) 01/2020 - 01/2017
2	Hypertension (High Blood Pressure) 01/2020 - 01/2016
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019 - 01/2019
2	Disease Progression 01/2019 - 04/2014
2	Birth Weight (Birth Weights) 01/2018 - 10/2003
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2017 - 01/2016
2	Pathologic Complete Response 11/2016 - 04/2013
2	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2016 - 01/2012
2	Leukopenia 01/2015 - 10/2014
2	Liver Diseases (Liver Disease) 10/2014 - 06/2006
2	Pneumonia (Pneumonitis) 01/2012 - 01/2002
2	Chromosome Aberrations (Chromosome Abnormalities) 08/2006 - 06/2003
1	Death (Near-Death Experience) 10/2022

Drug/Important Bio-Agent (IBA)

40	Methotrexate (Mexate)FDA LinkGeneric 05/2022 - 04/2003
33	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 05/2022 - 04/2003
29	Asparaginase (Elspar)FDA Link 11/2022 - 08/2002
19	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2002
17	Thioguanine (Tioguanine)FDA Link 05/2022 - 01/2009
11	NucleotidesIBA 01/2022 - 08/2010
10	2-mercaptopurineIBA 05/2022 - 06/2013
9	EnzymesIBA 11/2022 - 01/2012
9	Pharmaceutical PreparationsIBA 01/2022 - 10/2004
8	pegaspargase (Oncaspar)FDA Link 01/2022 - 01/2015
8	thiopurine methyltransferase (thiopurine S-methyltransferase)IBA 01/2021 - 08/2010
7	Biological ProductsIBA 01/2022 - 06/2003
5	antiarrhythmic peptide (AAP)IBA 01/2022 - 04/2014
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2006
4	ORALIT (ORS)IBA 01/2022 - 04/2010
4	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2016 - 08/2003
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2012
3	Dexamethasone (Maxidex)FDA LinkGeneric 07/2020 - 08/2003
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2002
3	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2009
3	AntibodiesIBA 02/2018 - 08/2002
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 11/2008
3	Prednisolone (Predate)FDA LinkGeneric 11/2016 - 06/2003
2	AntiemeticsIBA 01/2022 - 05/2020
2	insulin receptor-related receptor (IRR)IBA 01/2022 - 11/2021
2	Morphine (MS Contin)FDA LinkGeneric 11/2021 - 07/2012
2	purineIBA 11/2021 - 01/2020
2	LipidsIBA 01/2020 - 01/2020
2	Insulin (Novolin)FDA Link 01/2019 - 01/2017
2	CreatinineIBA 01/2019 - 01/2018
2	Infliximab (Remicade)FDA Link 02/2018 - 01/2018
2	VaccinesIBA 01/2017 - 11/2016
2	Transaminases (Aminotransferases)IBA 01/2015 - 10/2014
2	AntimetabolitesIBA 01/2012 - 06/2011
2	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2012 - 01/2002
2	Adrenocorticotropic Hormone (ACTH)FDA Link 08/2011 - 08/2003
2	Etoposide (VP 16)FDA LinkGeneric 10/2006 - 10/2004
2	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 06/2006 - 11/2002
2	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2006 - 10/2004

Therapy/Procedure

88	Therapeutics 05/2022 - 01/2002
29	Drug Therapy (Chemotherapy) 01/2022 - 06/2002
7	Aftercare (After-Treatment) 01/2021 - 08/2003
6	Radiotherapy 01/2022 - 01/2003
2	Hormonal Contraception 01/2022 - 10/2018
2	Treatment Delay 10/2020 - 02/2016
2	Transplantation 01/2019 - 07/2013
2	Artificial Respiration (Mechanical Ventilation) 01/2019 - 01/2017
2	Stem Cell Transplantation 07/2013 - 04/2011
2	Drug Tapering 11/2008 - 10/2006
2	Maintenance Chemotherapy 04/2003 - 06/2002